ASTA Draft Risk Profile Comments

ASTA submitted comments to the Food and Drug Administration(FDA) in August 2022 in response and support of the FDA's Draft Guidance for FDA Staff and Stakeholders: Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Ac. ASTA comments note that this Draft Guidance provides a science-based framework for protecting public health with respect to allergen issues.

In July 2025, ASTA signed onto a multi-industry letter requesting an extension to the comment period for FDA's "Tool for the Prioritization of Food Chemicals for Post-Market Assessment."